START PATIENT ASSESSMENT
Pneumococcal vaccination in adults is relatively complicated as it considers a variety of patient factors:
Most patients can receive the vaccine safely while in hospital
Recovering from infections such as pneumonia has little negative impact on lymphocyte ability to produce antibodies
In fact, patients are more likely to accept a vaccine while they are in hospital due to increased health awareness
Administer the appropriate vaccine towards the end of the hospital stay
When to delay the Pneumococcal vaccine
When not to delay
There are two products currently available for use in adults. They vary in their immunogenicity, the strains of pneumococcus they cover, how they can be given and their efficacy in different patient populations.
Pneumovax 23 - pneumococcal polysaccharide vaccine
Prevnar 13 - pneumococcal conjugate vaccine
This pathway was developed combining best practice guidelines, unique factors pertaining to Island Health and vaccine funding in BC
Advisory Committee on Immunization Practices, 2015
Center for Disease Control
BC Provincial Immunization Guide
This pathway is specific to inpatients at Island Health hospitals where both Prevnar 13 and Penumovax 23 are available free of charge.
While this pathway is equally valid for outpatients, outpatient vaccines may not be covered despite being recommended. In these scenarios, a recommendation will provide guidance on eligibility, pricing and where to obtain these products.